Rallybio (RLYB) Equity Ratio (2023 - 2025)
Rallybio (RLYB) has disclosed Equity Ratio for 3 consecutive years, with 0.93 as the latest value for Q4 2025.
- Quarterly Equity Ratio rose 2.83% to 0.93 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.93 through Dec 2025, up 2.83% year-over-year, with the annual reading at 0.93 for FY2025, 2.83% up from the prior year.
- Equity Ratio hit 0.93 in Q4 2025 for Rallybio, roughly flat from 0.93 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q1 2023 to a low of 0.87 in Q2 2024.
- Historically, Equity Ratio has averaged 0.92 across 3 years, with a median of 0.92 in 2023.
- Biggest five-year swings in Equity Ratio: decreased 8.26% in 2024 and later increased 4.1% in 2025.
- Year by year, Equity Ratio stood at 0.92 in 2023, then dropped by 1.43% to 0.91 in 2024, then increased by 2.83% to 0.93 in 2025.
- Business Quant data shows Equity Ratio for RLYB at 0.93 in Q4 2025, 0.93 in Q3 2025, and 0.9 in Q2 2025.